2026-07-24T06:43:49Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/77782023-07-19T04:16:08Zcom_20.500.14352_14col_20.500.14352_15

Transdiagnostic group cognitive behavioural therapy for emotional disorders in primary care: the results of the PsicAP randomized controlled trial Cano Vindel, Antonio Muñoz-Navarro, Roger Moriana, Juan A. Ruiz-Rodríguez, Paloma Medrano, Leonardo Adrián González-Blanch, César Anxiety depression emotional disorders group psychotherapy randomized clinical trial somatization transdiagnostic Atención primaria y medicina de familia Psiquiatría Salud pública (Medicina) Psicología clínica y psicodiagnóstico Emoción y agresividad Psicología aplicada Psicólogos 3211 Psiquiatría 3212 Salud Pública 6101 Patología 6106.03 Emoción 6107 Psicología General Background. Emotional disorders are highly prevalent in primary care. We aimed to determine whether a transdiagnostic psychological therapy plus treatment-as-usual (TAU) is more efficacious than TAU alone in primary care adult patients. Methods. A randomized, two-arm, single-blind clinical trial was conducted in 22 primary care centres in Spain. A total of 1061 adult patients with emotional disorders were enrolled. The transdiagnostic protocol (n = 527) consisted of seven 90-min sessions (8–10 patients) delivered over a 12–14-week period. TAU (n = 534) consisted of regular consultations with a general practitioner. Primary outcome measures were self-reported symptoms of anxiety, depression, and somatizations. Secondary outcome measures were functioning and quality of life. Patients were assessed at baseline, post-treatment, and at 3, 6, and 12 months. Intention-to-treat and per-protocol analyses were performed. Results. Post-treatment primary outcomes were significantly better in the transdiagnostic group compared to TAU (anxiety: p < 0.001; Morris's d = −0.65; depression: p < 0.001; d = −0.58, and somatic symptoms: p < 0.001; d = −0.40). These effects were sustained at the 12-month follow-up (anxiety: p < 0.001; d = −0.44; depression: p < 0.001; d = −0.36 and somatic symptoms: p < 0.001; d = −0.32). The transdiagnostic group also had significantly better outcomes on functioning (d = 0.16–0.33) and quality of life domains (d = 0.24–0.42), with sustained improvement at the 12-month follow-up in functioning (d = 0.25–0.39) and quality of life (d = 0.58–0.72). Reliable recovery rates showed large between-group effect sizes (d > 0.80) in favour of the transdiagnostic group after treatment and at the 12-month follow-up. Conclusions. Adding a brief transdiagnostic psychological intervention to TAU may significantly improve outcomes in emotional disorders treated in primary care. Trial Registration, isrctn.org identifier: ISRCTN58437086 Ministerio de Ciencia e Innovación (MICINN) IDIVAL Fundación Española para la Promoción y el Desarrollo Científico y Profesional de la Psicología Depto. de Psicología Experimental, Procesos Cognitivos y Logopedia Fac. de Psicología TRUE pub 2023-06-17T08:58:27Z 2023-06-17T08:58:27Z 2021-02-08 journal article https://hdl.handle.net/20.500.14352/7778 0033-2917 10.1017/S0033291720005498 eng (PSI2012-36589; PID2019-107243RB-C21) (INNVAL 16/08 and PRIMVAL 18/03) Atribución-NoComercial-SinDerivadas 3.0 España https://creativecommons.org/licenses/by-nc-nd/3.0/es/ open access application/pdf Cambridge University Press